IL151327A0 - 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents - Google Patents

8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents

Info

Publication number
IL151327A0
IL151327A0 IL15132701A IL15132701A IL151327A0 IL 151327 A0 IL151327 A0 IL 151327A0 IL 15132701 A IL15132701 A IL 15132701A IL 15132701 A IL15132701 A IL 15132701A IL 151327 A0 IL151327 A0 IL 151327A0
Authority
IL
Israel
Prior art keywords
indeno
medicaments
dihydro
substituted
production
Prior art date
Application number
IL15132701A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL151327A0 publication Critical patent/IL151327A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fuses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL15132701A 2000-02-23 2001-02-12 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents IL151327A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008275 2000-02-23
PCT/EP2001/001499 WO2001062746A1 (fr) 2000-02-23 2001-02-12 Derives de 8,8a-dihydro-3ah-indeno[1,2-d]thiazoles substitues a la position 8a, procedes de fabrication et utilisation en tant qu'agents pharmaceutiques par ex. en tant qu'anorexigenes

Publications (1)

Publication Number Publication Date
IL151327A0 true IL151327A0 (en) 2003-04-10

Family

ID=7631989

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15132701A IL151327A0 (en) 2000-02-23 2001-02-12 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents

Country Status (27)

Country Link
US (1) US6403624B1 (fr)
EP (1) EP1259498B1 (fr)
JP (1) JP4898052B2 (fr)
KR (1) KR20020079891A (fr)
CN (1) CN1195747C (fr)
AT (1) ATE283265T1 (fr)
AU (1) AU781003B2 (fr)
BR (1) BR0108605A (fr)
CA (1) CA2400698A1 (fr)
CZ (1) CZ20022838A3 (fr)
DE (1) DE50104600D1 (fr)
EE (1) EE200200466A (fr)
ES (1) ES2231482T3 (fr)
HK (1) HK1055117A1 (fr)
HR (1) HRP20020688A2 (fr)
HU (1) HUP0300140A3 (fr)
IL (1) IL151327A0 (fr)
MX (1) MXPA02007021A (fr)
NO (1) NO20023978L (fr)
NZ (1) NZ520926A (fr)
PL (1) PL357547A1 (fr)
PT (1) PT1259498E (fr)
RU (1) RU2261860C2 (fr)
SK (1) SK12162002A3 (fr)
WO (1) WO2001062746A1 (fr)
YU (1) YU56302A (fr)
ZA (1) ZA200206487B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142660A1 (de) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142659A1 (de) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1734963A4 (fr) 2004-04-02 2008-06-18 Merck & Co Inc Methode destinee a traiter des hommes presentant des troubles metaboliques et anthropometriques
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP3241839B1 (fr) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
AU2009307884B2 (en) 2008-10-22 2014-07-31 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
US8895596B2 (en) 2010-02-25 2014-11-25 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN105001219A (zh) 2011-02-25 2015-10-28 默沙东公司 用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物
WO2012118972A2 (fr) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Procédé de préparation d'agonistes du guanylate cyclase c
KR20150036245A (ko) 2012-08-02 2015-04-07 머크 샤프 앤드 돔 코포레이션 항당뇨병 트리시클릭 화합물
BR112015019836A2 (pt) 2013-02-22 2017-07-18 Merck Sharp & Dohme composto, composição farmacêutica, e, uso de um composto
EP2970119B1 (fr) 2013-03-14 2021-11-03 Merck Sharp & Dohme Corp. Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
WO2015051496A1 (fr) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Composés tricycliques antidiabétiques
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
US10968232B2 (en) 2016-12-20 2021-04-06 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP1259498B1 (fr) 2004-11-24
ZA200206487B (en) 2003-10-16
PL357547A1 (en) 2004-07-26
SK12162002A3 (sk) 2003-02-04
NZ520926A (en) 2004-08-27
YU56302A (sh) 2005-11-28
US20020058658A1 (en) 2002-05-16
CN1195747C (zh) 2005-04-06
CN1423640A (zh) 2003-06-11
US6403624B1 (en) 2002-06-11
CZ20022838A3 (cs) 2002-11-13
ES2231482T3 (es) 2005-05-16
KR20020079891A (ko) 2002-10-19
EE200200466A (et) 2003-12-15
AU5615301A (en) 2001-09-03
CA2400698A1 (fr) 2001-08-30
JP2003528825A (ja) 2003-09-30
NO20023978L (no) 2002-10-18
MXPA02007021A (es) 2003-03-27
HUP0300140A2 (en) 2003-05-28
HRP20020688A2 (en) 2004-12-31
WO2001062746A1 (fr) 2001-08-30
JP4898052B2 (ja) 2012-03-14
BR0108605A (pt) 2002-11-19
ATE283265T1 (de) 2004-12-15
PT1259498E (pt) 2005-02-28
HK1055117A1 (en) 2003-12-24
RU2261860C2 (ru) 2005-10-10
DE50104600D1 (de) 2004-12-30
NO20023978D0 (no) 2002-08-21
HUP0300140A3 (en) 2004-10-28
EP1259498A1 (fr) 2002-11-27
RU2002125460A (ru) 2004-01-10
AU781003B2 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
IL151327A0 (en) 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
MXPA04001307A (es) Compuestos biciclicos aromaticos sustituidos con aminoalquilo, metodo para la produccion de los mismos y su uso como farmacos.
HK1052515A1 (en) 8,8A-dihydro-indenoÄ1,2-DÜthiazole derivatives with a sulphonmido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament.
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
PL1682528T3 (pl) Pochodne benzo[b][1,4]dioksepiny
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
GEP20063759B (en) Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same
HK1042300A1 (en) Polycyclic thiazole systems and their utilization as anorectics.
GEP20063758B (en) Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators
IL151326A0 (en) Substituted 8, 8a-dihydro-3ah-indeno[1,2-d] thiazoles, a method for their production and their use as medicaments
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
GEP20063757B (en) Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.
DE50008905D1 (de) Polycyclische thiazol-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2000046193A3 (fr) Derives d'ether